Prelude Capital Management’s Aveanna Healthcare AVAH Stock Holding History

Prelude Capital Management’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Buy	38,646 +708	+2%	+$5.47K	0.02%	799
2025 Q4	$310K	Buy	37,938 +6,317	+20%	+$57.1K	0.02%	779
2025 Q3	$280K	Buy	31,621 +4,385	+16%	+$27.7K	0.02%	767
2025 Q2	$142K	Buy	27,236 +13,408	+97%	+$68.2K	0.01%	864
2025 Q1	$74.9K	Buy	+13,828	New	+$65.2K	0.01%	1064
2022 Q2	–	Sell	-33,900	Closed	-$116K	–	1810
2022 Q1	$116K	Sell	33,900 -12,400	-27%	-$67.3K	﹤0.01%	1383
2021 Q4	$343K	Buy	46,300 +300	+0.7%	+$2.18K	0.01%	1237
2021 Q3	$369K	Sell	46,000 -1,793	-4%	-$17.4K	0.01%	1037
2021 Q2	$591K	Buy	+47,793	New	+$567K	0.02%	858

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $233M AUM 18.82% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Prelude Capital Management's AVAH Position: Q1 2026 in Review

Prelude Capital Management increased its Aveanna Healthcare (AVAH) stake by 1.9% in Q1 2026, buying an estimated $5.47K and bringing the position to 38,646 shares worth $249K. The position accounts for 0.02% of the portfolio, ranked #799.

Prelude Capital Management first reported a position in AVAH in Q2 2021 and has held it in 9 quarters since. The position peaked at $591K in Q2 2021. 198 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

Prelude Capital Management held 38,646 shares of Aveanna Healthcare worth $249K as of Q1 2026.
Prelude Capital Management bought 708 Aveanna Healthcare shares in Q1 2026, an estimated $5.47K.
Aveanna Healthcare made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #799 holding.
Prelude Capital Management first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 9 quarters since.
Prelude Capital Management's Aveanna Healthcare position peaked at $591K in Q2 2021.
198 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.